Home

Andrew Combs

CIK 1825005 · Chief Chemistry Officer · last filed 2026-02-05

Andrew Combs is a Chief Chemistry Officer who has filed 11 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing, for PRLD, was dated Feb 5, 2026. Across all open-market trades the lifetime net is +$268.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.20M

Companies

1

Total Filings

11

Lifetime Open-Market Net

$268.7K

Filer Profile

Reported Address
C/O PRELUDE THERAPEUTICS INCORPORATED
200 POWDER MILL ROAD
WILMINGTON, DE 19803
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PRLD Chief Chemistry Officer 480,123 $4.59 $2.20M $268.7K 11 2026-02-05

Recent Filings

11 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-02-05 PRLD Grant (A) — $0 EDGAR
2025-03-27 PRLD Buy (P) +100,000 $69.2K EDGAR
2025-02-05 PRLD Grant (A) — $0 EDGAR
2024-12-26 PRLD Buy (P) +63,075 $85.5K EDGAR
2024-03-04 PRLD Grant (A) — $0 EDGAR
2023-02-09 PRLD Grant (A) — $0 EDGAR
2022-04-04 PRLD Exer (M) +36,062 $68.2K EDGAR
2022-02-17 PRLD Grant (A) — $0 EDGAR
2021-12-15 PRLD Buy (P) +8,000 $94.9K EDGAR
2021-07-22 PRLD Grant (A) — $0 EDGAR
Showing 1–10 of 11
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.